The aim of this study was to investigate the effect of hyperinsulinemia on the first and second phase of arginine-induced insulin release in humans. Seven healthy subjects underwent three studies (lasting 360 min): a control study using saline infusion and two euglycemic clamps using a low-dose (0.33 mU · kg−1 · min−1) and a high-dose (1.20 mU · kg−1 · min−1) insulin infusion. After a 3-h equilibration period, arginine (25 g) was infused for 30 min, and insulin and C-peptide responses to arginine were followed for 180 min. At the end of the equilibration period, before arginine administration, steady-state insulin levels were (means ± SE) 60.0 ± 2.4, 165.6 ± 1.8, and 455.4 ± 7.8 pmol/l during saline, low-dose, and high-dose insulin infusions, respectively. The time course of insulin release during the arginine test was calculated from C-peptide concentrations by using C-peptide kinetic modeling and deconvolution. In particular, first-phase and second-phase insulin response was obtained by integrating the time course of the insulin release during either the first 5 min or the following 40 min of the arginine test, respectively. Whereas first-phase insulin release was independent of any effect induced by either insulin infusion, second-phase insulin release was reduced in a similar degree by both insulin infusion doses. First phase was 75.5 ± 10.1, 73.7 ± 12.8, and 73.4 ± 10.3 pmol/kg, whereas second phase was 266.1 ± 46.0, 143.1 ± 33.5, and 133.0 ± 30.2 pmol/kg for saline, low-dose, and high-dose insulin infusions, respectively. We conclude that second-phase, but not first-phase, arginine-induced insulin release is modulated by the pre-stimulus insulin levels. In addition, the inhibitory effect exerted by insulin on second-phase insulin response to arginine appears to be maximized at insulin levels only four times basal.
Skip Nav Destination
Article navigation
Original Articles|
September 01 1994
Hyperinsulinemia Decreases Second-Phase But Not First-Phase Arginine-Induced Insulin Release in Humans
Piero M Piatti;
Piero M Piatti
Istituto Scientiflco San Raffaele, Cattedra di Clinica Medica, Universita di Milano
Milan
Search for other works by this author on:
Antonio E Pontiroli;
Antonio E Pontiroli
Istituto Scientiflco San Raffaele, Cattedra di Clinica Medica, Universita di Milano
Milan
Search for other works by this author on:
Andrea Caumo;
Andrea Caumo
Istituto Scientiflco San Raffaele, Cattedra di Clinica Medica, Universita di Milano
Milan
Search for other works by this author on:
Giovanni Santambrogio;
Giovanni Santambrogio
Istituto Scientiflco San Raffaele, Cattedra di Clinica Medica, Universita di Milano
Milan
Search for other works by this author on:
Lucilla D Monti;
Lucilla D Monti
Istituto Scientiflco San Raffaele, Cattedra di Clinica Medica, Universita di Milano
Milan
Search for other works by this author on:
Sabrina Costa;
Sabrina Costa
Istituto Scientiflco San Raffaele, Cattedra di Clinica Medica, Universita di Milano
Milan
Search for other works by this author on:
Francesca Garbetta;
Francesca Garbetta
Istituto Scientiflco San Raffaele, Cattedra di Clinica Medica, Universita di Milano
Milan
Search for other works by this author on:
Laura Baruffaldi;
Laura Baruffaldi
Istituto Scientiflco San Raffaele, Cattedra di Clinica Medica, Universita di Milano
Milan
Search for other works by this author on:
Claudio Cobelli;
Claudio Cobelli
Dipartimento di Elettronica ed Informatica, Universita' di Padova
Padua, Italy
Istituto Scientiflco San Raffaele, Cattedra di Clinica Medica, Universita di Milano
Milan
Search for other works by this author on:
Guido Pozza
Guido Pozza
Istituto Scientiflco San Raffaele, Cattedra di Clinica Medica, Universita di Milano
Milan
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Piero M. Piatti, Istituto Scientifico San Raffaele, Via Olgettina 60, 20132 Milan, Italy.
Diabetes 1994;43(9):1157–1163
Article history
Received:
April 22 1993
Revision Received:
May 18 1994
Accepted:
May 18 1994
PubMed:
7915241
Citation
Piero M Piatti, Antonio E Pontiroli, Andrea Caumo, Giovanni Santambrogio, Lucilla D Monti, Sabrina Costa, Francesca Garbetta, Laura Baruffaldi, Claudio Cobelli, Guido Pozza; Hyperinsulinemia Decreases Second-Phase But Not First-Phase Arginine-Induced Insulin Release in Humans. Diabetes 1 September 1994; 43 (9): 1157–1163. https://doi.org/10.2337/diab.43.9.1157
Download citation file:
21
Views